联泓新科拟向科院生物增资1.5亿元

Core Viewpoint - The company is focusing on biodegradable materials as a key strategic development direction, with plans to increase capital for its subsidiary to enhance its financial structure [1] Group 1: Company Strategy - The company announced a capital increase of 150 million yuan to its subsidiary, Jiangxi Academy of Biological New Materials Co., Ltd. [1] - The subsidiary primarily engages in the research, production, and sales of lactic acid and polylactic acid [1] - Other shareholders of the subsidiary will not participate in this capital increase [1]